Abg-Wtt Global Life Science Capital Partners Gp Ltd

Investment Portfolio & 13F Holdings Analysis

About
CIK: 0001832108
Type: FundHoldings: 4Value: $38.3MLatest: 2025Q1

ABG-WTT Global Life Science Capital Partners GP Ltd is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 4 holdings worth $0.0 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
4
Total Value
38322526
Accession Number
0000950123-25-005578
Form Type
13F-HR
Manager Name
Abgwtt-Global-Life-Science-Capital-Partners-Gp
Data Enrichment
100% identified
4 identified0 unidentified

Holdings

4 positions • $38.3M total value
Manager:
Search and click to pin securities to the top
Ceribell, Inc.
Shares:1.1M
Value:$20.9M
% of Portfolio:54.5% ($20.9M/$38.3M)
CG Oncology, Inc.
Shares:495.5K
Value:$12.1M
% of Portfolio:31.7% ($12.1M/$38.3M)
RAPID MICRO BIOSYSTEMS, INC.
Shares:1.8M
Value:$4.9M
% of Portfolio:12.7% ($4.9M/$38.3M)
Pulmonx Corp
Shares:60.2K
Value:$405.2K
% of Portfolio:1.1% ($405.2K/$38.3M)